Trump and Chinese president Xi end summit without major agreement on AI
US President Donald Trump and Chinese President Xi Jinping concluded a three-day summit without a major agreement on artificial intelligence. The meeting in Washington focused on personal rapport and extended a trade truce by two months. Despite the presence of top US tech executives at a White House dinner, no AI breakthrough occurred. This outcome disappointed experts who hoped for a pause in the AI arms race between the two nations.
The summit's failure to address AI collaboration is a missed opportunity for global AI governance. Ro Khanna, a leading Democrat on the House China committee, called it a "layup" for a statesmanlike agreement on technical working groups. Trump, however, prioritized rebranding AI as "super intelligence" and maintaining a US lead, showing little interest in a joint framework.
For Asia, this non-agreement means continued competitive pressure. Chinese AI companies like DeepSeek, Moonshot, and Alibaba will face ongoing pressure to innovate independently. The absence of a US-China working group means no shared standards or safeguards are likely for the near future, impacting regional AI development and adoption strategies.
The key thing to watch is whether China's stated goal of 90% penetration for next-generation smart terminals and AI agents by 2030 shifts. Without a collaborative framework, China will push its own AI development, potentially accelerating its domestic market and further diverging from US-led standards. This will affect how Asian countries choose their AI partners.
Related reading
6 stories
China overtakes US as top workplace for elite AI researchers, study finds
The US-China AI competition is intensifying, as our past coverage showed China overtaking the US in elite AI researchers.
How Alibaba is using AI to revamp its mapping app – and take on Meituan
Chinese AI companies like Alibaba face pressure to innovate independently amid the lack of US-China collaboration.
China’s biotech firms move up value chain as drug deals evolve beyond licensing: analysts
Pinglu Canal underscores China’s turn toward Southeast Asia
Radenta Academy offers Fortinet cybersecurity courses
